Oxaliplatin-based chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oxaliplatin-based chemotherapy, covering 2024-12-10 to 2024-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature [Phase 3]